Bajpai Trupti, Pandey Maneesha, Varma Meena, Bhatambare Ganesh S
Department of Microbiology, Sri Aurobindo Institute of Medical Sciences Medical College and PG Institute, Indore, Madhya Pradesh, India.
Indian J Pathol Microbiol. 2014 Jul-Sep;57(3):407-12. doi: 10.4103/0377-4929.138733.
Antimicrobial resistance showed by different uropathogens is one of the barricades that might hinder a successful treatment. Detection of extended spectrum beta-lactamase (ESBL) production among uropathogens is an important marker of endemicity.
The present prospective study was done to identify the trends of uropathogens, to find the prevalence of ESBL isolates and to study the antibiotic resistance profile of the ESBL and non-ESBL uropathogenic isolates.
This study was conducted in the Department of Microbiology of a teaching tertiary care hospital from July 2013 to September 2013. All the uropathogenic isolates were identified up to species level by conventional methods. The prevalence of potential ESBL producers was explored. Antibiotic resistance test of the urinary isolates was done by disc-diffusion method and the results were interpreted according to Clinical Laboratory Standards Institute-2013 guidelines.
A total of 670 urine samples from male and female patients visiting the outpatient department (OPD) and inpatient department (IPD) of our hospital were collected. A significantly higher number of IPD and OPD males (55.1% and 55.5%) were found to be culture positive. Escherichia coli (55.3%) was the most frequently isolated uropathogen followed by Klebsiella pneumoniae (23%). However, strains of Escherichia coli (41.6%) were the highest ESBL producing isolates followed by Pseudomonas aeruginosa (36.1%). ESBL producing isolates were found to be multidrug-resistant when compared to non-ESBL producers. However, excessive drug-resistance among non-ESBL producing isolates can't be ignored.
Our study confirms a global trend toward increased resistance to beta-lactam antibiotics. We emphasize on the formulation of antibiotic policy for a particular geographical area.
不同尿路病原体表现出的抗菌药物耐药性是可能阻碍治疗成功的障碍之一。检测尿路病原体中产超广谱β-内酰胺酶(ESBL)是地方性流行的一个重要标志。
本前瞻性研究旨在确定尿路病原体的趋势,找出ESBL分离株的流行情况,并研究ESBL和非ESBL尿路致病性分离株的抗生素耐药谱。
本研究于2013年7月至2013年9月在一家教学三级护理医院的微生物科进行。所有尿路致病性分离株均通过常规方法鉴定到种水平。探索潜在ESBL产生菌的流行情况。采用纸片扩散法对尿液分离株进行抗生素耐药试验,并根据临床实验室标准协会2013年指南解释结果。
共收集了我院门诊(OPD)和住院部(IPD)男女患者的670份尿液样本。发现住院部和门诊男性的培养阳性率显著更高(分别为55.1%和55.5%)。大肠埃希菌(55.3%)是最常分离出的尿路病原体,其次是肺炎克雷伯菌(23%)。然而,大肠埃希菌菌株(41.6%)是产ESBL最高的分离株,其次是铜绿假单胞菌(36.1%)。与非ESBL产生菌相比,产ESBL分离株被发现具有多重耐药性。然而,非ESBL产生菌中的过度耐药性也不容忽视。
我们的研究证实了对β-内酰胺类抗生素耐药性增加的全球趋势。我们强调针对特定地理区域制定抗生素政策。